GoldenGolden
Advanced Search
Medison Pharma

Medison Pharma

Medison is one of the world’s largest commercial partners of leading global biotech companies.

Help us improve this page by adding information.
Visit our Writing Guide or this topic page for additional help.

Timeline

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services

News

Title
Author
Date
Publisher
Description
Biohaven Pharmaceutical Holding Company Ltd.
March 10, 2021
www.prnewswire.com:443
/PRNewswire/ -- Biohaven Pharmaceutical Holding Company Ltd. (NYSE: BHVN) ("Biohaven") and Medison Pharma announced today that NURTEC® ODT (rimegepant) was...
Rigel Pharmaceuticals, Inc.; Medison Pharma
November 23, 2020
www.prnewswire.com:443
/PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) and Medison Pharma (Medison) today announced that Health Canada has approved the new drug submission...
BioSpace
November 17, 2020
BioSpace
Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of FDA-approved products for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) and related disorders, and Medison Pharma ("Medison"), a leading international commercial partner for highly innovat
Tris Pharma, Inc.
November 17, 2020
www.prnewswire.com:443
/PRNewswire/ -- Tris Pharma, Inc. ("Tris"), a specialty pharmaceutical company with a robust portfolio of FDA-approved products for the treatment of Attention...
Medison Pharma
November 6, 2020
www.prnewswire.com:443
/PRNewswire/ -- Medison Pharma ist ein weltweit führender Handelspartner für hochmoderne Therapien. Das Unternehmen hat heute seine exklusive...
BioSpace
November 6, 2020
BioSpace
Medison Pharma, a leading international commercial partner for highly innovative therapies, today announced an exclusive distribution agreement with Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) to commercialize QINLOCK, a switch-control tyrosine kinase inhibitor, in Canada and Israel for the treatment of fourth-line gastrointestinal stromal tumor (GIST).
Medison Pharma
November 6, 2020
www.prnewswire.com:443
/PRNewswire/ -- Medison Pharma, a leading international commercial partner for highly innovative therapies, today announced an exclusive distribution agreement...
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.